Article
Cardiovascular disease after hematopoietic cell transplantation - lessons learned
31 Jul 2008
Abstract excerpt
Hematopoietic cell transplantation (HCT) has now become the treatment of choice for a large number of malignant and non-malignant diseases.[1][1] It is quite clear that unless effective targeted therapy becomes available, HCT will continue to be offered as a curative therapeutic modality to patients
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
